课题基金 / 基金详情

PArkin Co-Regulated Gene (PACRG), parkin and Parkinsonism.

PArkin Co-Regulated Gene (PACRG), parkin and Parkinsonism.
PArkin 协同调节基因 (PACRG)、parkin 和帕金森病。
批准号:
nhmrc : 334349
负责人:
A/Pr Paul Lockhart
金额:
$26.52万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31

项目摘要

项目成果

A/Pr Paul Lockhart的其他基金

相似基金

相关文献

中文摘要
翻译
帕金森病(PD)是一种常见的神经退行性疾病,影响超过2%的65岁以上的人。这种疾病的特征是震颤、运动缓慢、僵硬和姿势不稳定。目前的治疗方案可以提供某种程度的症状缓解,但目前没有治疗方法来停止或减缓这种使人衰弱的疾病的进展。PD目前在澳大利亚影响约35,000人,预计随着人口老龄化,这一数字将显着增加。PD是一种复杂的疾病,病因和发病机制尚不清楚。然而,在过去的10年中,已经确定了几个基因,当被破坏时可以导致PD。我们已经发现了一个新的基因,我们相信它可能与PD有关。该提案的总体目标是阐明该基因及其在PD发展中的作用。了解该基因的表达和功能可能会大大促进我们对这种疾病的理解。利用这些结果,我们的目标是在细胞和动物系统中模拟帕金森病;这些可能为PD中受干扰的分子途径提供强有力的见解,并为开发新的治疗方法以减轻或预防这种疾病提供了一种手段。
英文摘要
Parkinson's disease (PD) is a common neurodegenerative disorder affecting greater than two percent of individuals over the age of 65. The disease is characterised by tremor, slowness of movement, rigidity and postural instability. Current treatment regimes may provide some measure of symptomatic relief, but currently there is no treatment to halt or slow the progression of this debilitating disease. PD currently affects an estimated 35,000 people in Australia and this figure is predicted to increase significantly as the population ages. PD is a complex disorder, the causes and disease mechanisms are not well understood. However, in the past 10 years several genes have been identified that can cause PD when disrupted. We have identified a new gene that we believe may be involved in PD. The overall aim of this proposal is to characterise this gene and what role it plays in the development of PD. Understanding the expression and function of this gene may significantly advance our understanding of this disorder. Using these results, we aim to model Parkinson's disease in cellular and animal systems; these may provide powerful insight into the molecular pathway(s) perturbed in PD and a means to develop novel therapeutic approaches to alleviate or prevent the disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tuberous sclerosis and epilepsy: using resected tissue to understand pathogenesis and inform management
  • 批准号:
    nhmrc : 1128933
  • 项目类别:
    Project Grants
  • 资助金额:
    $23.1万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Paul Lockhart
  • 依托单位:
Tuberous sclerosis and epilepsy: using resected tissue to understand pathogenesis and inform management
  • 批准号:
    nhmrc : GNT1128933
  • 项目类别:
    Project Grants
  • 资助金额:
    $33.93万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Paul Lockhart
  • 依托单位:
Understanding the Neurobiology of Autism Spectrum Disorder
  • 批准号:
    nhmrc : GNT1098255
  • 项目类别:
    Project Grants
  • 资助金额:
    $163.07万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Paul Lockhart
  • 依托单位:
Understanding the Neurobiology of Autism Spectrum Disorder
  • 批准号:
    nhmrc : 1098255
  • 项目类别:
    Project Grants
  • 资助金额:
    $112.38万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Paul Lockhart
  • 依托单位:
国内基金
海外基金
多孔氮碳负载碱土金属修饰Cu/Cu₂O光催化CO₂还原及机理研究
  • 批准号:
    JCZRLH202601411
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
铜簇负载型MXene催化剂设计及其催化CO₂加氢制甲醇机理的理论研究
  • 批准号:
    2026JJ70020
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    李燕丽
  • 依托单位:
CO2响应型二维多孔Janus催化剂构筑及油/水界面催化调控机制研究
  • 批准号:
    2026JJ80297
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    李超平
  • 依托单位:
光辅助Li-CO2电池中MoS2催化剂性能调控及机理研究
  • 批准号:
    2026JJ90008
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    赵亭亭
  • 依托单位: